Technique to Measure ctDNA May Improve Metastatic Cancer Surveillance
Monitoring absolute ctDNA concentrations using a dual-threshold model may significantly improve metastatic cancer surveillance.
Read MorePosted by Chris Wolski | Feb 26, 2025 | Molecular Diagnostics |
Monitoring absolute ctDNA concentrations using a dual-threshold model may significantly improve metastatic cancer surveillance.
Read MorePosted by Chris Wolski | Feb 3, 2025 | Allergy & Autoimmune |
Though the most common tick-related infection, Lyme disease is easy to treat, but hard to diagnose. Virax Biolabs is aiming to change that.
Read MorePosted by Andy Lundin | Jan 13, 2025 | Cervical (HPV) |
Naveris expanded the commercial availability of its NavDx test, a non-invasive tool for detecting MRD in HPV-positive anal cancer patients.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Diagnostic Technologies |
Researchers developed an optimized pooled testing framework, enabling faster, cost-effective, and accurate infectious disease screening.
Read MorePosted by Andy Lundin | Nov 13, 2024 | Covid 19 |
The AMP published a consensus report on best practices for SARS-CoV-2 genomic surveillance using next-generation sequencing (NGS).
Read More